Stock Data
$0.04 (4.07%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. The company is headquartered in Smiths Falls, Canada.
Canopy Growth reports at 7:00 AM ET, and with the market cap down to $416 million, cash burn and adjusted EBITDA matter more than any Schedule III headline. Rescheduling optimism has done the lifting for cannabis names; this report shows whether the business underneath is catching up.
Canopy Growth is on the cusp of profitability after losses of $0.40 per share, banking on a 68% surge in international cannabis sales and a strengthened $131.3M net cash balance to reach positive adjusted EBITDA in FY2027. CEO Luc Mongeau framed the turnaround bluntly: the company reset, cut costs, and made strategic bets including the MTL Cannabis acquisition that position it to extend medical cannabis leadership from Canada into Europe.
80 Articles
Our top personal finance-related articles today. Your wallet will thank you later.
